Evofem Biosciences (EVFM) News Today → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free EVFM Stock Alerts $0.01 0.00 (-16.67%) (As of 05/17/2024 08:55 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15, 2024 | investorplace.comEVFM Stock Earnings: Evofem Biosciences Reported Results for Q1 2024May 15, 2024 | prnewswire.comEvofem Biosciences Announces Financial Results for the First Quarter of 2024April 18, 2024 | prnewswire.comEvofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTOApril 17, 2024 | finance.yahoo.comEvofem Biosciences, Inc. (EVFM)April 17, 2024 | finance.yahoo.comEvofem Biosciences, Inc. (EVFM) stock forecast and price targetMarch 27, 2024 | msn.comEVFM Stock Earnings: Evofem Biosciences Reported Results for Q4 2023March 27, 2024 | prnewswire.comEvofem Reports $18.2 million of Phexxi Net Product Sales in 2023March 20, 2024 | finanznachrichten.deEvofem Biosciences, Inc.: Evofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-CalMarch 7, 2024 | prnewswire.comFor Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended PregnancyFebruary 23, 2024 | benzinga.comEvofem Biosciences Stock (OTC:EVFM) Insider TradesFebruary 23, 2024 | benzinga.comEvofem Biosciences Stock (OTC:EVFM), Short Interest ReportFebruary 13, 2024 | investing.comEvofem Biosciences Inc (EVFM)February 7, 2024 | markets.businessinsider.comAditxt, Inc. Restructures Debt Post-Merger with EvofemFebruary 1, 2024 | msn.comEvofem Biosciences Announces Merger Agreement with AditxtFebruary 1, 2024 | msn.comEvofem Biosciences achieves 2023 prelim net product sales of $18.1M to $18.3MFebruary 1, 2024 | finance.yahoo.comEvofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023January 8, 2024 | finance.yahoo.comWashington State HCA Removes Prior Authorization for Hormone-Free "In the Moment" Contraceptive PHEXXI Ahead of Huskies vs. Wolverines Championship GameJanuary 3, 2024 | morningstar.comEvofem Biosciences Inc EVFMDecember 19, 2023 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, EVFM, AEZS, HOLIDecember 18, 2023 | businesswire.comEVOFEM BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Evofem Biosciences, Inc. - EVFMDecember 13, 2023 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSTR, CVLY, EVFM, EARDecember 12, 2023 | realmoney.thestreet.comEvofem just downgraded at Laidlaw, here's whyDecember 12, 2023 | marketwatch.comShares of Aditxt, Evofem Surge on $100 Million Acquisition DealDecember 12, 2023 | markets.businessinsider.comAditxt To Acquire Evofem For $100 Mln; ADTX Stock SoarDecember 12, 2023 | tmcnet.comEVFM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Evofem Biosciences, Inc. Is Fair to ShareholdersDecember 12, 2023 | msn.comAditxt to acquire women’s health company Evofem BiosciencesDecember 12, 2023 | finance.yahoo.comAditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women GloballyNovember 14, 2023 | finanznachrichten.deEvofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2023November 14, 2023 | msn.comEvofem Biosciences GAAP EPS of $0.10, revenue of $5.11MNovember 14, 2023 | finance.yahoo.comEvofem Biosciences Announces Financial Results for the Third Quarter of 2023October 24, 2023 | msn.comEvofem Biosciences expects to see third consecutive quarter of growthOctober 24, 2023 | finance.yahoo.comEvofem Biosciences Announces Preliminary Results for the Third Quarter of 2023October 13, 2023 | finance.yahoo.comEvofem to Participate in the Virtual Investor Ask the CEO ConferenceSeptember 27, 2023 | finance.yahoo.comEvofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem's Phexxi Patents ExpireSeptember 11, 2023 | finance.yahoo.comEvofem Biosciences Successfully Amends S.P.A. with Institutional InvestorAugust 22, 2023 | finance.yahoo.comEvofem Biosciences Signs Non-Binding Letter of Intent to Enable Listing on a National Stock ExchangeAugust 15, 2023 | finanznachrichten.deEvofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Second Quarter of 2023August 14, 2023 | finance.yahoo.comEvofem Biosciences Announces Financial Results for the Second Quarter of 2023July 22, 2023 | fool.comEvofem Biosciences (OTC: EVFM)July 13, 2023 | ca.finance.yahoo.comEVFM - Evofem Biosciences, Inc.July 6, 2023 | finance.yahoo.comEvofem to Participate in the Virtual Investor Summer Spotlight SeriesJune 19, 2023 | msn.comEvofem Biosciences GAAP EPS of -$1.85, revenue of $5.81M; reaffirms FY23 EBIDTA outlookJune 16, 2023 | finance.yahoo.comEvofem Biosciences Announces Financial Results for the First Quarter of 2023June 1, 2023 | finance.yahoo.comEvofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023May 18, 2023 | finanznachrichten.deEvofem Biosciences, Inc.: Evofem Biosciences Announces 1-for-125 Reverse Stock SplitMay 17, 2023 | finance.yahoo.comEvofem Biosciences Announces 1-for-125 Reverse Stock SplitMay 11, 2023 | investing.comEvofem Biosciences (EVFM) Earnings Dates & ReportsApril 28, 2023 | finanznachrichten.deEvofem Biosciences, Inc.: Evofem Biosciences Reports Year-End 2022 Financial Results and Provides Corporate UpdateApril 28, 2023 | finance.yahoo.comEvofem Biosciences Reports Year-End 2022 Financial Results and Provides Corporate UpdateApril 14, 2023 | finance.yahoo.comEvofem Appoints Ivy Zhang as Chief Financial Officer and Secretary Get Evofem Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVFM and its competitors with MarketBeat's FREE daily newsletter. Email Address 41 banks launch ‘crypto dollar’ (Ad)Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here). Here's how you capitalize (including #1 crypto to play it). EVFM Media Mentions By Week EVFM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVFM News Sentiment▼0.160.42▲Average Medical News Sentiment EVFM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVFM Articles This Week▼30▲EVFM Articles Average Week Get Evofem Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVFM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sunshine Biopharma News SciSparc News Evelo Biosciences News Histogen News Bellerophon Therapeutics News Lucy Scientific Discovery News Comera Life Sciences News GRI Bio News Aditxt News China SXT Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVFM) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evofem Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
